A new PCSK9 inhibitor (recaticimab) injected every one to three months may work safely and provide more flexible dosing to lower cholesterol, according to late-breaking science presented today at the American Heart Association’s Scientific Sessions 2023.
Recaticimab injection every 1-3 months may safely lower bad cholesterol
- Post author:
- Post published:November 13, 2023
- Post category:uncategorized